Senior Director, LCM Program Management

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone.  Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor.  Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”

Mineralys is a fully remote company.

Senior Director, Life Cycle Management (LCM) Program Management

The Senior Director, Life Cycle Management (LCM) Program Management is a strategic leadership role responsible for governing and driving the end-to-end life cycle management strategy for the lorundrostat program. This leader partners closely with Clinical Development, Regulatory, CMC, Commercial, Medical Affairs, Finance, and Corporate Leadership to ensure that life cycle opportunities are prioritized, and executed.

The Senior Director serves as the enterprise LCM orchestrator, translating Corporate strategy into integrated, executable life cycle plans, establishing fit-for‑-‑purpose governance, and enabling data-driven decision making at the GPT and Executive levels. This role requires comfort operating in ambiguity, influencing without authority, and balancing near-term execution with long-term value creation in a rapidly evolving setting.

Principal Responsibilities

• Serve as the Program Management Lead for life cycle initiatives, coordinating cross-functional teams across Clinical Development, Regulatory, CMC, Commercial, Medical Affairs, Market Access, Safety, Quality, and Operations.
• Evaluate, and prioritize life cycle opportunities, risks, and trade-offs aligned with corporate strateg